Broadcom (AVGO) Stock Forecast for November 2026: Bull, Base and Bear Scenarios

Analysis date: October 31, 2026. Broadcom (NASDAQ: AVGO) enters November after a sharp selloff, but a one-day decline does not establish where the stock will finish the next month. AVGO closed the regular U.S. session on Friday, October 30 at $326.08 per share, down $18.92, or approximately 5.48%, from Thursday’s $345.00 close. The final regular-session reference is 4:00 p.m. New York time, Eastern Daylight Time (EDT, UTC−04:00), on October 30, equivalent to 20:00 UTC. The $326.08 figure is corroborated by Nasdaq Dorsey Wright’s October 30 market data. This is a dated closing benchmark, not a live November quote or an after-hours price.

The Broadcom stock forecast for November 2026 hinges on three different questions: whether investors continue paying a premium for custom AI accelerators and networking; whether concerns over financing exposure and customer concentration deepen; and whether U.S. economic data change the market’s appetite for richly valued semiconductor shares. Below are conditional bull, base, and bear scenarios for November 2–30, 2026, not claims about future results.

What is actually known entering November?

Broadcom’s most recent reported quarterly figures were for fiscal Q3, ended August 2, 2026. On September 2, the company announced revenue of approximately $29.6 billion and $16.7 billion of AI semiconductor revenue. Management said it expected fiscal Q4 AI semiconductor revenue of approximately $21.7 billion and total Q4 revenue near $34.8 billion. Those Q4 numbers are company guidance, not reported actuals. The company’s fiscal Q4 ends November 1, but the quarter-end date is not an earnings announcement date. See Broadcom’s September 2 fiscal Q3 release.

The company sells both semiconductors and infrastructure software. AI customers’ orders for custom XPUs and networking equipment matter disproportionately to investor expectations, but software cash generation, execution costs, and manufacturing capacity also affect the broader case. Broadcom’s fiscal Q3 Form 10-Q describes important exposures, including customer concentration, dependence on external manufacturing and supply-chain relationships, and the scale of capital required for AI deployments.

Why the $63 billion Anthropic financing deal cuts both ways

On October 26, financial partners announced a $63 billion special-purpose-vehicle (SPV) financing structure to buy Broadcom-designed AI accelerators and networking solutions and lease the equipment to Anthropic. The announcement says deliveries are expected to begin in calendar 2027. Consequently, $63 billion is not immediate Broadcom sales, recognized revenue, or November cash flow. The structure may enable future demand, but there is a gap between financing commitments, equipment deliveries, accounting recognition, and free cash flow. Read the October 26 transaction announcement.

The risk side is unusually important. In its October 27 filing, Broadcom described residual-value support tied to the SPV, a contingent obligation that could arise following a lease default and a shortfall in equipment value. Broadcom stated that its maximum potential liability upon deployment, on an undiscounted basis, is approximately $43 billion; this is a conditional maximum, not a statement that a loss has occurred or is expected in November. The filing says the support amount builds as equipment is deployed and declines as lease payments are made. See Broadcom’s October 27 Form 8-K. A change in market perception of this support can move AVGO even without an immediate change in reported chip revenue.

AVGO November 2026 forecast: three conditional scenarios

The outcomes below refer to the direction and behavior of AVGO through the November 30 regular-session close. They are analytical cases, not probabilities, price targets, or investment recommendations. The October 29 close of $345.00 and October 30 close of $326.08 are historical reference points, not guaranteed resistance or support.

Why the cases are separate: In the bull case, fresh evidence must strengthen investors’ confidence beyond the already published guidance. In the base case, the market has insufficient new facts to reprice the business decisively. In the bear case, the valuation or financing risk premium rises even if long-term AI demand remains substantial. A single strong or weak trading day is insufficient to confirm any scenario.

A transparent price stress test—not an analyst target

Readers seeking numbers can use a simple, reproducible hypothetical sensitivity exercise anchored to the October 30 regular-session close of $326.08. Select percentage changes for illustration only, multiply $326.08 by (1 + the selected return), and round to cents. With a five-percentage-point central threshold and a 15-percentage-point outer stress threshold, this produces the following illustrative November 30 price bands:

For example, $326.08 × 1.15 = $374.992, displayed as $374.99. The 5% and 15% shocks are deliberately chosen scenario assumptions, not measured November volatility, Wall Street consensus, discounted-cash-flow values, or statistically estimated confidence intervals. These bands are neither exhaustive nor floors and ceilings: AVGO could trade outside them, and the company’s intrinsic value cannot be inferred from the calculation.

November dates that could change the outcome

The following macro releases are scheduled, not known results, as of October 31. The Bureau of Labor Statistics lists both at 8:30 a.m. New York time. U.S. daylight saving time ends November 1, so the releases are in Eastern Standard Time (EST, UTC−05:00), equivalent to 13:30 UTC. See the official BLS November 2026 release schedule.

• Friday, November 6, 2026 — October employment report, 8:30 a.m. EST (13:30 UTC). An unexpectedly strong or weak labor report could influence Treasury yields and investors’ willingness to hold high-multiple technology shares. The direction of AVGO’s response is not automatic; inflation expectations and broader risk sentiment also matter.
• Tuesday, November 10, 2026 — October Consumer Price Index, 8:30 a.m. EST (13:30 UTC). A surprise in inflation could shift rate expectations and the valuation applied to future AI earnings. Any market interpretation belongs to the November release, not to today’s forecast.

The Fed’s published 2026 calendar shows regular FOMC meetings on October 27–28 and December 8–9, not a regular November rate decision. Unscheduled policy developments remain possible, but should not be treated as calendar events. See the Federal Reserve’s 2026 FOMC calendar. Investors should check the BLS and Fed calendars again near each release because schedules can change.

Five evidence checks to revisit throughout November

1. AI accelerator orders versus guidance: Distinguish an actual new order, shipment or revised management outlook from repeated discussion of September’s Q4 expectations. The latter is already public information.
2. Networking demand and deployment execution: Watch for credible updates on connectivity hardware, system-level deployments, manufacturing bottlenecks and delivery timing—not simply announcements of large AI spending ambitions.
3. Customer concentration: Look for changes in the spending intentions or financing access of the relatively small group of large AI buyers. A reduction by a major customer may affect growth more than broadly favorable industry commentary.
4. Financing and residual-value exposure: Prioritize SEC filings explaining obligations, guarantees, funding tranches, asset-value assumptions or contractual changes. The October transaction headline alone cannot determine net economic benefit.
5. Valuation and sector sentiment: Compare price movements with new expectations for revenue, margin and free cash flow, as well as movements in semiconductor peers and interest-rate-sensitive growth stocks. A cheaper share price by itself does not prove undervaluation.

Bottom line: what would change the November view?

As of October 31, the clearest confirmed operating foundation is Broadcom’s strong reported fiscal Q3 AI semiconductor growth and ambitious fiscal Q4 guidance. The important new complication is the October 26 financing arrangement: it may help fund large deployments beginning in 2027, but it also creates a contingent residual-value exposure that investors must assess independently of revenue opportunities.

For November, a bullish revision needs credible evidence of demand conversion and manageable financing risks; a bearish revision needs deterioration in operating or funding expectations, or persistent valuation pressure; otherwise choppy consolidation remains a coherent base case. Recheck official filings and the economic calendar before interpreting any new price move. This is general market analysis, not personalized financial advice.